Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases

Pediatric Rheumatology

Volumn 7, Issue , 2009, Pages

  Sperber, Kirk ^a   Hom, Christine ^a   Chao, Chun ^a   Shapiro, Deborah ^a   Ash, Julia ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; PLACEBO; PREDNISONE;

AUTOIMMUNE DISEASE; CLINICAL TRIAL; CONGENITAL MALFORMATION; DATA BASE; DRUG DOSE COMPARISON; DRUG MEGADOSE; FETUS DEATH; HUMAN; INCIDENCE; LIVE BIRTH; META ANALYSIS; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW;

EID: 67449135232     PISSN: None     EISSN: 15460096     Source Type: Journal    
DOI: 10.1186/1546-0096-7-9     Document Type: Review

References (48)

1. Rynes RI Antimalarial drugs in the treatment of rheumatic diseases Br J Rheumatol 1997, 36:799-805 10.1093/rheumatology/36.7.799 9255117
2. Mellman I Fuchs R Helerius A Acidification of the endocytic and exocytic pathways Annu Rev Biochem 1986, 55:663-700 10.1146/ annurev.bi.55.070186.003311 2874766
3. Oda K Kariyama Y Yomada E Ikahara Y Effects of weakly basic amines on proteolytic processing and terminal glycosylation of secretory proteins in rat hepatocytes Biochem J 1986, 240:739-745 1147481 3493770
4. Kyburg D Bretano F Gay S Mode of action of Hydroxychloroquine in RA-evidence of an inhibiting effect on toll-like receptor signaling Nat Clin Pract Rheumatol 2006, 1:458-459 10.1038/ncprheum0292
5. Fessler BJ Alarcon GS McGwin G Jr Roseman J Bastian HM Friedman AW et al the LUMINA study group Systemic lupus erythematosus in three ethnic groups. XVI. Association of Hydroxychloroquine use with reduced risk of damage accrual Arthritis Rheum 2005, 52:1473-1480 10.1002/art.21039 15880829
6. Emery P Suarez-Almazor M Rheumatoid arthritis Clin Evid 2003, 9:1349-1371 15366179
7. Vroom F de Walle HE Laar van de MA Brouwers JR Berg de Jong-van den LT Disease-modifying antirheumatic drugs in pregnancy: Current status and implications for the future Drug Saf 2006, 29:845-63 10.2165/ 00002018-200629100-00003 16970509
8. Temprano KK Bandlamudi R Moore T Antirheumatic drugs in pregnancy and lactation Semin Arthritis Rheum 2005, 35:112-21 10.1016/ j.semarthrit.2005.05.002 16194696
9. Hart CW Naunton RF The ototoxicity of chloroquine phosphate Arch Otolaryngol 1964, 80:407-412 14198705
10. Santaella RM Fraunfelder FW Ocular adverse effects associated with systemic medications: Recognition and management Drugs 2007, 67:75-93 10.2165/00003495-200767010-00006 17209665
11. Stafford-Brady FJ Urowitz MB Gladman DD Easterbrook M Lupus retinopathy: patterns, associations, and prognosis Arthritis Rheum 1988, 31:1105-1110 10.1002/art.1780310904 3422014
12. Costedoat-Chalumeau N Amoura Z Aymard G Le TH Wechsler B Vauthier D Dermer ME Darbois Y Piette JC Evidence of transplacental passage of hydroxychloroquine in humans Arthritis Rheum 2002, 46:1123-4 10.1002/ art.10150 11953993
13. Ostensen M Khamashta M Lockshin M Parke A et al Anti-inflammatory and immunosuppressive drugs and reproduction Arthritis Research and Therapy 2006, 8:1-19 10.1186/ar1957
14. Costedoat-Chalumeau N Amoura Z Huong DL Lechat P Piette JC Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature Autoimmun Rev 2005, 4:111-5 10.1016/ j.autrev.2004.11.009 15722258
15. Borden MB Parke AL Antimalarial drugs in systemic lupus erythematosus: use in pregnancy Drug Saf 2001, 24:1055-63 10.2165/ 00002018-200124140-00004 11735661
16. Khamashta MA Buchanan NM Hughes GR The use of hydroxychloroquine in lupus pregnancy: The British experience Lupus 1996, 5(Suppl 1):S65-6 10.1177/096120339600500114 8803914
17. Stroup DF Berlin JA Morton SC Olkin I Williamson GD Rennie D Moher D Becker BJ Sipe TA Thacker SB Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group JAMA 2000, 283:2008-12 10.1001/ jama.283.15.2008 10789670
18. Egger M Smith GD Altman DG eds Systematic reviews in health care: meta-analysis in context BMJ Books: London 2 2002
19. Downs SH Black N The feasibility of creating a checklist for the assessment of the methodological quality both of randomized and non-randomized studies of health care interventions J Epidemiol Community Health 1998, 6:377-84 10.1136/jech.52.6.377
20. Martell BA O'Connor PG Kerns RD Becker WC Morales KH Kosten RD Fiellin FA Systematic Review: Opioid Treatment for Chronic Back Pain: Prevalence, Efficacy, and Association with Addiction Ann Intern Med 2007, 146:116-127 17227935
21. Review Manager (RevMan) [computer program] Version 4.2 for Windows Copenhagen: The Nordic Centre 2003
22. DerSimonian R Liard N Meta-analysis in clinical trials Control Clin Trials 1986, 7:177-188 10.1016/0197-2456(86)90046-2 3802833
23. Harbord RM Egger M Sterne JA A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints Stat Med 2006, 25:3443-57 10.1002/sim.2380 16345038
24. Deeks JJ Altman DG Bradburn MJ Statistical methods for examining heterogeneity and combing results from several studies in a meta-analysis Systematic Reviews and Healthcare: Meta-analysis in context London BMJ Publications Egger M, Davey Smith G, Altman DG 2002
25. Higgins JP Thompson SG Deeks JJ Altman DG Measuring inconsistency in meta-analysis BMJ 2003, 327:577-560 10.1136/bmj.327.7414.557
26. Hully SB Cummings SR Browner WS Grady D Hearst N Newman TB Designing clinical research Philadelphia: Lipponcott Williams, and Wilkens 2 2001, 65-91
27. Clowse ME Magder L Witter F Petri M Hydroxychloroquine in lupus pregnancy Arthritis Rheum 2006, 54:3640-3647 10.1002/art.22159 17075810
28. Costedoat-Chalumeau N Amoura Z Duhaut P Huong DL Sebbough D Wechsler B Vauthier D Denjoy I Lupoglazoff JM Piette JC Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group Arthritis Rheum 2003, 48:3207-11 10.1002/art.11304 14613284
29. Buchanan NM Toubi E Khamashta MA Lima F Kerslake S Hughes GR Hydroxychloroquine and lupus pregnancy: Review of a series of 36 cases Ann Rheum Dis 1996, 55:486-468 1010215 8774170 10.1136/ard.55.7.486
30. Frassi M Biasini C Taglieti M Daneli E et al Hydroxychloroquine in pregnant patients with rheumatic disease: A case control observation of 76 treated pregnancies Lupus 2004, 13:755
31. Levy RA Vilela VS Cataldo MJ Ramos RC Duarte JL Tura BR Albuquerque EM Jesus NR Hydroxychloroquine (HCQ) in lupus pregnancy: Double-blind and placebo-controlled study Lupus 2001, 10:401-404 10.1191/ 096120301678646137 11434574
32. Khan KS Kunz R Kleijnen J Antes G Systematic reviews to support evidence-based medicine London: Royal Society of Medicine Press 2003, 87-96
33. Ulberg S Lindquist NG Sjostrand SE Accumulation of chorioretinotoxic drugs in the foetal eye Nature 1970, 227:1257-1258 10.1038/2271257a0 5452818
34. Garner P Gülmezoglu AM Drugs for preventing malaria in pregnant women Cochrane Database of Systematic Reviews 2006, 4 CD000169
35. Motta M Tincani A Faden D Zinzini E Lojacono A Marchesi A Frassi M Biasini C Zatti S Chirico G Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation J Perinatol 2005, 25:86-9 10.1038/sj.jp.7211208 15496869
36. Motta M Tincani A Faden D Zinzini E Chirico G Antimalarial agents in pregnancy Lancet 2002, 359:524-5 10.1016/S0140-6736(02)07643-2 11853823
37. Klinger G Morad Y Westall CA Laskin C Spitzer KA Koren G Ito S Buncic RJ Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases Lancet 2001, 358:813-4 10.1016/ S0140-6736(01)06004-4 11564493
38. Parke A West B Hydroxychloroquine in pregnant patients with systemic lupus erythematosus J Rheumatol 1996, 23:1715-8 8895146
39. Levy M Buskila D Gladman DD Urowitz MB Koren G Pregnancy outcome following first trimester exposure to chloroquine Am J Perinatol 1991, 8:174-178 10.1055/s-2007-999371 2029276
40. Suhonen Hydroxychloroquine administration in pregnancy Arch Dermatol 1983, 119:185-6 10.1001/archderm.119.3.185a 6824351
41. Petri M Systemic lupus erythematosus and pregnancy Rheum Dis Clin North Am 1994, 13:732-739
42. Kitridou RC Mintz G The fetus in systemic lupus erythematous Dubois's lupus erthymatosus Philadelphia: Lea and Febiger Wallace DJ, Hahn BH 4 1992, 508-515
43. Mintz G Niz J Guttierez G Garcia Alonso A Karchmer S Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach J Rheumatol 1986, 13:732-739 3772921
44. Lockshin MD Lupus pregnancy Clin Rheum Dis 1985, 11:611-632 3935365
45. Lockshin MD Reinitz E Druzin ML Murrman M Este D Lupus pregnancy case-control prospective study demonstrate absence of lupus exacerbation during or after pregnancy Am J Med 1984, 77:893-888 10.1016/ 0002-9343(84)90538-2 6496544
46. Petri M Allbritton J Fetal outcome of lupus pregnancy: A retrospective case-controlled study of the Hopkins lupus cohort J Rheumatol 1993, 20:650-666 8496859
47. Nossent HC Swaak TJG Sysyemic lupus erythematosus. VI: Analysis of the interrelationship with pregnancy J Rheumatol 1990, 17:771-776 2388198
48. Van Walraven C Mahon JL Maher D Bohm C Loupecis A Surveying physicians to determine the minimal important difference: Implications for sample size calculations J Clin Epidemiol 1999, 52:717-723 10.1016/ S0895-4356(99)00050-5 10465315